Federal National Mortgage Association Fannie Mae (FNMA) financial statements (2021 and earlier)
Company profile
Business Address |
MIDTOWN CENTER WASHINGTON, DC 20005 |
State of Incorp. | |
Fiscal Year End | December 31 |
SIC | 6111 - Federal and Federally-Sponsored Credit Agencies (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 69,307 | 67,424 | 66,789 | 65,786 | 54,582 | 53,527 | 49,996 | ||
Cash and cash equivalents | 21,184 | 25,557 | 32,110 | 25,224 | 14,674 | 22,023 | 19,228 | ||
Short-term investments | 48,123 | 41,867 | 34,679 | 40,562 | 39,908 | 31,504 | 30,768 | ||
Total current assets: | 69,307 | 67,424 | 66,789 | 65,786 | 54,582 | 53,527 | 49,996 | ||
Noncurrent Assets | |||||||||
Other undisclosed assets | 3,434,012 | 3,350,894 | 3,278,740 | 3,222,182 | 3,167,335 | 3,194,649 | 3,220,112 | ||
TOTAL ASSETS: | 3,503,319 | 3,418,318 | 3,345,529 | 3,287,968 | 3,221,917 | 3,248,176 | 3,270,108 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Debt | 24,896 | 33,756 | 35,579 | 71,950 | 106,572 | 74,449 | |||
Total current liabilities: | 24,896 | 33,756 | 35,579 | 71,950 | 106,572 | 74,449 | |||
Noncurrent Liabilities | |||||||||
Other undisclosed liabilities | 3,488,711 | 3,387,182 | 3,315,459 | 3,246,318 | 3,145,908 | 3,137,884 | 3,186,068 | ||
Total liabilities: | 3,488,711 | 3,412,078 | 3,349,215 | 3,281,897 | 3,217,858 | 3,244,456 | 3,260,517 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 14,608 | 6,240 | (120,835) | 6,071 | 4,030 | 3,680 | 9,541 | ||
Preferred stock | 19,130 | 19,130 | 19,130 | 19,130 | 19,130 | 19,130 | 19,130 | ||
Common stock | 687 | 687 | 687 | 687 | 687 | 687 | 687 | ||
Treasury stock, value | (7,400) | (7,400) | (7,400) | (7,401) | (7,401) | (7,401) | (7,401) | ||
Accumulated other comprehensive income | 131 | 322 | 553 | 759 | 1,407 | 1,733 | 1,203 | ||
Accumulated deficit | (118,776) | (127,335) | (133,805) | (124,253) | (126,942) | (127,618) | (121,227) | ||
Other undisclosed stockholders' equity attributable to parent | 120,836 | 120,836 | 117,149 | 117,149 | 117,149 | 117,149 | |||
Stockholders' equity attributable to noncontrolling interest | 29 | 40 | |||||||
Other undisclosed stockholders' equity | 117,149 | 50 | |||||||
Total stockholders' equity: | 14,608 | 6,240 | (3,686) | 6,071 | 4,059 | 3,720 | 9,591 | ||
TOTAL LIABILITIES AND EQUITY: | 3,503,319 | 3,418,318 | 3,345,529 | 3,287,968 | 3,221,917 | 3,248,176 | 3,270,108 |
Income statement (P&L) ($ in millions)
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
---|---|---|---|---|---|---|---|---|
Net investment income | 117,770 | 115,483 | 108,815 | 104,885 | 107,842 | 112,230 | ||
Gross profit: | 119,008 | 115,927 | 109,538 | 104,885 | 107,970 | 112,405 | ||
Operating expenses | (3,023) | (3,059) | (2,737) | (2,741) | (3,050) | (3,853) | (2,545) | |
Other operating income, net (Noninterest Income, Other Operating Income) | 1,176 | 979 | 2,227 | 966 | 1,348 | 5,887 | 3,930 | |
Operating income: | 117,161 | 113,847 | 109,028 | 103,110 | 106,268 | 114,439 | 1,385 | |
Nonoperating income (Investment Income, Nonoperating) | 642 | 972 | 347 | 846 | 297 | |||
Interest and debt expense | (98,610) | (96,098) | (89,123) | (84,726) | (88,025) | (94,371) | (95,014) | |
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (974) | 2,350 | (2,100) | (1,023) | (2,382) | 236 | 131,899 | |
Income from continuing operations before equity method investments, income taxes: | 17,577 | 20,099 | 18,447 | 18,333 | 16,208 | 21,150 | 38,567 | |
Income from equity method investments | 269 | 517 | ||||||
Income from continuing operations before income taxes: | 17,577 | 20,099 | 18,447 | 18,333 | 16,208 | 21,419 | 39,084 | |
Income tax expense (benefit) | (3,417) | (4,140) | (15,984) | (6,020) | (5,253) | (6,941) | 45,415 | |
Income before gain (loss) on sale of properties: | 14,160 | 15,959 | 2,463 | 12,313 | 10,955 | 14,478 | 84,499 | |
Other undisclosed net loss | (269) | (517) | ||||||
Net income: | 14,160 | 15,959 | 2,463 | 12,313 | 10,955 | 14,209 | 83,982 | |
Net loss attributable to noncontrolling interest | (1) | (1) | (19) | |||||
Net income attributable to parent: | 14,160 | 15,959 | 2,463 | 12,313 | 10,954 | 14,208 | 83,963 | |
Preferred stock dividends and other adjustments | (13,969) | (12,613) | (8,944) | (12,236) | (11,216) | (15,323) | (85,419) | |
Net income (loss) available to common stockholders, diluted: | 191 | 3,346 | (6,481) | 77 | (262) | (1,115) | (1,456) |
Comprehensive Income ($ in millions)
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 14,160 | 15,959 | 2,463 | 12,313 | 10,955 | 14,209 | 83,982 | |
Other comprehensive income (loss) | (191) | (348) | 206 | (648) | (326) | 530 | 819 | |
Other undisclosed comprehensive loss | (412) | |||||||
Comprehensive income: | 13,969 | 15,611 | 2,257 | 11,665 | 10,629 | 14,739 | 84,801 | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (1) | (1) | 19 | |||||
Other undisclosed comprehensive loss, net of tax, attributable to parent | (38) | |||||||
Comprehensive income, net of tax, attributable to parent: | 13,969 | 15,611 | 2,257 | 11,665 | 10,628 | 14,738 | 84,782 |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.